Contract HHSN302201600130P
Swift Biosciences, Inc. · Department Of Health And Human Services · May 19, 2016
Swift Biosciences, Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on May 19, 2016 for $6,000 of work in biological product (except diagnostic) manufacturing. Performance is in Ann Arbor, MI. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 18, 2020.
Contract details
- PIID
- HHSN302201600130P
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Ann Arbor, MI
- First action
- May 19, 2016
- Latest action
- December 18, 2020
Description
BIOLOGICAL PRODUCTS
Modification timeline
-
December 18, 2020Mod P00001$-36
-
May 19, 2016Base awardSWIFT BIOSCIENCES, INC.:1268107 [16-005132]$6.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSN302201600130P?
Contract HHSN302201600130P is a federal contract awarded to Swift Biosciences, Inc. by Department Of Health And Human Services on May 19, 2016 for $6,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 1 time since the base award.
Who won contract HHSN302201600130P?
Swift Biosciences, Inc. won contract HHSN302201600130P from Department Of Health And Human Services.
How much is contract HHSN302201600130P worth?
Contract HHSN302201600130P has obligated $6,000 to date.